Sight Sciences, Inc. (SGHT)
9.50
+0.23
(+2.48%)
USD |
NASDAQ |
Sep 29, 15:03
Sight Sciences Enterprise Value : 469.44M for Sept. 28, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 28, 2026 | 469.44M |
| September 25, 2026 | 450.84M |
| September 24, 2026 | 437.16M |
| September 23, 2026 | 427.31M |
| September 22, 2026 | 432.23M |
| September 21, 2026 | 426.76M |
| September 18, 2026 | 401.05M |
| September 17, 2026 | 404.33M |
| September 16, 2026 | 407.61M |
| September 15, 2026 | 405.97M |
| September 14, 2026 | 407.06M |
| September 11, 2026 | 407.61M |
| September 10, 2026 | 400.22M |
| September 09, 2026 | 402.69M |
| September 08, 2026 | 405.42M |
| September 04, 2026 | 419.10M |
| September 03, 2026 | 420.74M |
| September 02, 2026 | 422.93M |
| September 01, 2026 | 410.35M |
| August 31, 2026 | 427.31M |
| August 28, 2026 | 430.05M |
| August 27, 2026 | 422.39M |
| August 26, 2026 | 420.20M |
| August 25, 2026 | 417.46M |
| August 24, 2026 | 420.74M |
| Date | Value |
|---|---|
| August 21, 2026 | 414.18M |
| August 20, 2026 | 408.16M |
| August 19, 2026 | 425.67M |
| August 18, 2026 | 411.99M |
| August 17, 2026 | 413.08M |
| August 14, 2026 | 407.61M |
| August 13, 2026 | 417.46M |
| August 12, 2026 | 415.27M |
| August 11, 2026 | 386.27M |
| August 10, 2026 | 383.54M |
| August 07, 2026 | 370.95M |
| August 06, 2026 | 350.16M |
| August 05, 2026 | 265.90M |
| August 04, 2026 | 270.82M |
| August 03, 2026 | 264.80M |
| July 31, 2026 | 250.03M |
| July 30, 2026 | 250.03M |
| July 29, 2026 | 254.41M |
| July 28, 2026 | 252.22M |
| July 27, 2026 | 242.37M |
| July 24, 2026 | 230.88M |
| July 23, 2026 | 219.39M |
| July 22, 2026 | 237.44M |
| July 21, 2026 | 230.88M |
| July 20, 2026 | 237.99M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Integra LifeSciences Holdings Corp. | 3.040B |
| Abbott Laboratories | 202.39B |
| AngioDynamics, Inc. | 605.12M |
| Alphatec Holdings, Inc. | 2.043B |
| AtriCure, Inc. | 2.877B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.446M |
| Revenue (Quarterly) | 23.39M |
| Total Expenses (Quarterly) | 27.83M |
| EPS Diluted (Quarterly) | -0.0816 |
| Gross Profit Margin (Quarterly) | 91.39% |
| Profit Margin (Quarterly) | -19.01% |
| Earnings Yield | -5.86% |
| Normalized Earnings Yield | -5.859 |